추천 제품
생물학적 소스
mouse
Quality Level
항체 형태
purified immunoglobulin
항체 생산 유형
primary antibodies
클론
monoclonal
종 반응성
human
제조업체/상표
Chemicon®
기술
ELISA: suitable
immunofluorescence: suitable
immunohistochemistry: suitable
western blot: suitable
동형
IgG1
배송 상태
wet ice
특이성
Specific to HCV NS5A
면역원
Recombinant protein to NS5A
애플리케이션
ELISA
Immunofluorescence
RIA
Western Blot
Optimal working dilutions must be determined by end user.
Immunofluorescence
RIA
Western Blot
Optimal working dilutions must be determined by end user.
Research Category
Infectious Diseases
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Infectious Diseases - Viral
This Anti-Hepatitis C Virus Antibody, NS5A is validated for use in ELISA, IF, WB, IH for the detection of Hepatitis C Virus.
물리적 형태
Format: Purified
Liquid 0.02M PB, 0.25M NaCl, 0.1% sodium azide
저장 및 안정성
Store at 2 to 8°C for up to 12 months from date of receipt.
법적 정보
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
면책조항
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
적합한 제품을 찾을 수 없으신가요?
당사의 제품 선택기 도구.을(를) 시도해 보세요.
Storage Class Code
12 - Non Combustible Liquids
WGK
WGK 2
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
시험 성적서(COA)
제품의 로트/배치 번호를 입력하여 시험 성적서(COA)을 검색하십시오. 로트 및 배치 번호는 제품 라벨에 있는 ‘로트’ 또는 ‘배치’라는 용어 뒤에서 찾을 수 있습니다.
Enhanced Ca2+ leak from ER Ca2+ stores induced by hepatitis C NS5A protein.
Biochemical and biophysical research communications null
Hepatitis C virus replication-specific inhibition of microRNA activity with self-cleavable allosteric ribozyme.
Nucleic Acid Therapeutics null
Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.
Journal of virology null
Molecules (Basel, Switzerland), 21(10) (2016-10-19)
Hepatitis C virus (HCV) infects 200 million people worldwide, and 75% of HCV cases progress into chronic infections, which consequently cause cirrhosis and hepatocellular carcinoma. HCV infection is treated with currently considered standard drugs, including direct anti-viral agents (DAAs), alone
Hepatitis C virus infection suppresses GLUT2 gene expression via downregulation of hepatocyte nuclear factor 1?.
Journal of virology null
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.